Detection of furosemide, sibutramine, and/or fluoxetine adulteration in “all natural” weight loss consumer products at an international mail facility satellite laboratory using handheld/portable rapid screening instruments

A total of 97 consumer products claiming to be "all natural" or providing label graphics indicating potential weight-loss effects, were examined by a US Food and Drug Administration (FDA) National Forensic Chemistry Center (NFCC) International Mail Facility (IMF) satellite laboratory. All products were examined using a toolkit consisting of a handheld Raman spectrometer, portable Fourier-transform infrared (FT-IR) spectrometer, portable ambient ionization direct analysis in real-time mass spectrometer (DART-MS), and/or portable gas chromatography-mass spectrometry (GC-MS) instrument. Conclusive results were achieved for 89 out of 97 products using the satellite laboratory toolkit only. The remaining eight products were sent to the NFCC full-service laboratory for additional analysis using liquid chromatography with mass spectrometry (LC-MS). All 97 products were found to be adulterated with active pharmaceutical ingredients (APIs), with each containing at least two of the following drugs: furosemide, sibutramine, and/or fluoxetine. Furosemide and fluoxetine are only available with a prescription and sibutramine is a Schedule IV controlled substance. Furthermore, sibutramine, fluoxetine, and furosemide are all under the scope of section 801(u) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and therefore have been identified by FDA as a significant public health risk. Overall, the results of this study helped prevent over 24,000 adulterated consumer product capsules from reaching unsuspecting American consumers during a two-year timeframe.

Authors

Institutions

Publication Details

Journal
Journal of Forensic Sciences
Published
2026-11-16
DOI
https://doi.org/10.1111/1556-4029.70482
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Detection of furosemide, sibutramine, and/or fluoxetine adulteration in “all natural” weight loss consumer products at an international mail facility satellite laboratory using handheld/portable rapid screening instruments

Lisa Lorenz, Teneka L Jean-Louis, Melissa E. Collins, Caroline Machal Kelley et al.
Journal of Forensic Sciences
Pharmaceutical Quality and Counterfeiting
article

Detection of furosemide, sibutramine, and/or fluoxetine adulteration in “all natural” weight loss consumer products at an international mail facility satellite laboratory using handheld/portable rapid screening instruments

Lisa Lorenz, Teneka L Jean-Louis, Melissa E. Collins, Caroline Machal Kelley, Adam C. Lanzarotta, Michael D. Thatcher, Marie Marseille, Sara E. Kern, Megan E. Sterling, Pan Jingjing, Anvi Patel, Christina Fernández, Brian L. Boyd, Joseph Carver, Hannah LaRoy, Allison Reimer, Daurice J. McClain, Jerae D. Byrd, Muhammad Altaf, Joan Cantellops Figueroa, Cierra D. Bell
article en

Abstract

A total of 97 consumer products claiming to be "all natural" or providing label graphics indicating potential weight-loss effects, were examined by a US Food and Drug Administration (FDA) National Forensic Chemistry Center (NFCC) International Mail Facility (IMF) satellite laboratory. All products were examined using a toolkit consisting of a handheld Raman spectrometer, portable Fourier-transform infrared (FT-IR) spectrometer, portable ambient ionization direct analysis in real-time mass spectrometer (DART-MS), and/or portable gas chromatography-mass spectrometry (GC-MS) instrument. Conclusive results were achieved for 89 out of 97 products using the satellite laboratory toolkit only. The remaining eight products were sent to the NFCC full-service laboratory for additional analysis using liquid chromatography with mass spectrometry (LC-MS). All 97 products were found to be adulterated with active pharmaceutical ingredients (APIs), with each containing at least two of the following drugs: furosemide, sibutramine, and/or fluoxetine. Furosemide and fluoxetine are only available with a prescription and sibutramine is a Schedule IV controlled substance. Furthermore, sibutramine, fluoxetine, and furosemide are all under the scope of section 801(u) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and therefore have been identified by FDA as a significant public health risk. Overall, the results of this study helped prevent over 24,000 adulterated consumer product capsules from reaching unsuspecting American consumers during a two-year timeframe.

Journal of Forensic Sciences
United States Food and Drug Administration (US)
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon